<h4>Background</h4>Fibroblast activation protein (FAP)-targeted tracers have emerged as promising agents for breast cancer imaging, with recent studies demonstrating PET performance comparable to or surpassing, that of [<sup>18</sup>F]FDG. This evidence concerns the gene FAP and breast carcinoma.